Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Japan Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20081
20111
20141
20161
20171
20181
20211
20222
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Boehringer Ingelheim2
Daiichi Sankyo2
Daiichi Sankyo Co., Ltd.2
Anthos Therapeutics, Inc.1
AstraZeneca1
Bristol-Myers Squibb1
CSL Behring1
Janssen Research & Development, LLC1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation14
Stroke4
Acute Coronary Syndrome1
Atherosclerosis1
Atrial Flutter1
Cardiovascular Diseases1
Coronary Artery Disease1
Embolism1
Heart Diseases1
Heart Failure1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.